21:08 IST
NSE
Dividend
Glenmark Pharmaceuticals Dividend
Glenmark Pharmaceuticals recommended a final dividend of ₹2.5 per equity share for FY2026. Shareholder approval at the upcoming general meeting is required for payment.
Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd news stories on ALFA NewsRead the news →- Share price
- ₹2,282.30
- Market cap
- ₹64,412 Cr
- Revenue (annual)
- ₹16,983 Cr
- Net profit (annual)
- ₹1,362 Cr
- P/E (TTM)
- 35.8×Sector 47.3×
- Promoter holding
- 46.65%+0.00% QoQ
- FII holding
- 20.89%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 7Product Launch 6Financial Results 4Other Announcement 3Business Update 3Results Update 2Regulatory Approval 2Legal & Regulatory 2Board Meeting Date 2Annual General Meeting 2Merger & Restructuring 1Management Change 1Employee Stock Options 1Dividend 1Debt & Borrowing 1Credit Rating 1
Time
1 announcement with these filters